Search
for
Sort by
Research 61–90 of 75
- A Systematic Scoping Review and Conceptual Analysis of New-Onset Fibromyalgia Manifestations After Non-Hospitalized COVID-19: Empirics, Definitions, Methodologies, Pathophysiology, Mapping of Literature, and Knowledge Gaps
- Relationship between Platelets, Plateletcrit and Lymphocytes in the Complete Blood Count and Recurrent Implantation Failure: A Retrospective Study
- Research progress of post-acute sequelae after SARS-CoV-2 infection
- From Hair Loss to Vision Loss: Minoxidil-Associated CRVO in a Young Female
- The Multisystem Impact of Long COVID: A Comprehensive Review
- Referee report. For: Case Report: Extensive digital gangrene as a primary manifestation of late-onset systemic lupus erythematosus [version 2; peer review: 2 approved]
- Hair disorders associated with post-COVID-19 infection in females: a cross-sectional study
- An overview of animal models induced by glucocorticoids
- What we already know about the Post-COVID-19 Syndrome: A narrative review
- Case Report: Extensive digital gangrene as a primary manifestation of late-onset systemic lupus erythematosus
- Efficacy of Activated Autologous Platelet-Rich Plasma in The Treatment of Diabetic Foot Ulcers: An Evidence-Based Brief Literature Review
- Referee report. For: Case Report: Extensive digital gangrene as a primary manifestation of late-onset systemic lupus erythematosus [version 2; peer review: 1 approved]
- Telogen Effluvium in Patients recovering from COVID-19
- Prominent Cutaneous Manifestation of COVID-19: A Case Report
- Chemical Constituents of Halophyte Suaeda glauca and Their Therapeutic Potential for Hair Loss
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Insulin Resistance Syndrome- the Sensitive IRS
- The Rare Occurrence of a Left Atrial Thrombus in a Dog
- New Drugs for Leukæmia and Tumours
- COVID-19 and Sex Differences
- Lupus erythematosus: systemic and cutaneous manifestations
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Combined hormonal contraception and venous thromboembolism
- Anabolic-androgenic steroids and cardiovascular risk
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- Menopausal Acne – Challenges And Solutions
- Oral medications for central serous chorioretinopathy: a literature review
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective